
Objectives: After completing this article, readers should be able to: 1. Discuss the common clinical presentations of pneumococcal infections. 2. Describe the resistance patterns of Streptococcus pneumoniae and the usual recommendations for therapy of pneumococcal infections. 3. Characterize the treatment of pneumococcal meningitis. 4. Delineate the differences between the two licensed pneumococcal vaccines and the indications for their administration. 5. Describe the impact of the conjugate pneumococcal vaccine on pneumococcal infection in the United States.
*Pneumococcal Infections, Drug Resistance, Bacterial, Drug Resistance, Microbial, Pediatrics, Pneumococcal Infections, Anti-Bacterial Agents, Meningitis, Bacterial, Pneumococcal Vaccines, Otitis Media, Microbial, Streptococcus pneumoniae, Risk Factors, Humans, Meningitis, Sinusitis, Child, Respiratory Tract Infections, Immunology and Infectious Disease
*Pneumococcal Infections, Drug Resistance, Bacterial, Drug Resistance, Microbial, Pediatrics, Pneumococcal Infections, Anti-Bacterial Agents, Meningitis, Bacterial, Pneumococcal Vaccines, Otitis Media, Microbial, Streptococcus pneumoniae, Risk Factors, Humans, Meningitis, Sinusitis, Child, Respiratory Tract Infections, Immunology and Infectious Disease
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 7 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
